These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
800 related items for PubMed ID: 29270239
1. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC). Pu W, Wang C, Chen S, Zhao D, Zhou Y, Ma Y, Wang Y, Li C, Huang Z, Jin L, Guo S, Wang J, Wang M. Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239 [Abstract] [Full Text] [Related]
2. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients. Kuo IY, Chang JM, Jiang SS, Chen CH, Chang IS, Sheu BS, Lu PJ, Chang WL, Lai WW, Wang YC. Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140 [Abstract] [Full Text] [Related]
3. Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis. Li X, Zhou F, Jiang C, Wang Y, Lu Y, Yang F, Wang N, Yang H, Zheng Y, Zhang J. PLoS One; 2014; 9(7):e103162. PubMed ID: 25050929 [Abstract] [Full Text] [Related]
4. TFF1 hypermethylation and decreased expression in esophageal squamous cell carcinoma and histologically normal tumor surrounding esophageal cells. Gonzaga IM, Soares Lima SC, Nicolau MC, Nicolau-Neto P, da Costa NM, de Almeida Simão T, Hernandez-Vargas H, Herceg Z, Ribeiro Pinto LF. Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124 [Abstract] [Full Text] [Related]
5. Promoter methylation in cytology specimens as an early detection marker for esophageal squamous dysplasia and early esophageal squamous cell carcinoma. Adams L, Roth MJ, Abnet CC, Dawsey SP, Qiao YL, Wang GQ, Wei WQ, Lu N, Dawsey SM, Woodson K. Cancer Prev Res (Phila); 2008 Oct; 1(5):357-61. PubMed ID: 19137073 [Abstract] [Full Text] [Related]
6. Genome-wide methylation profiling identified methylated KCNA3 and OTOP2 as promising diagnostic markers for esophageal squamous cell carcinoma. Bian Y, Gao Y, Lu C, Tian B, Xin L, Lin H, Zhang Y, Zhang X, Zhou S, Wan K, Zhou J, Li Z, Chen H, Wang L. Chin Med J (Engl); 2024 Jul 20; 137(14):1724-1735. PubMed ID: 37650127 [Abstract] [Full Text] [Related]
7. Identification of Hyper-Methylated Tumor Suppressor Genes-Based Diagnostic Panel for Esophageal Squamous Cell Carcinoma (ESCC) in a Chinese Han Population. Wang C, Pu W, Zhao D, Zhou Y, Lu T, Chen S, He Z, Feng X, Wang Y, Li C, Li S, Jin L, Guo S, Wang J, Wang M. Front Genet; 2018 Jul 20; 9():356. PubMed ID: 30233644 [Abstract] [Full Text] [Related]
8. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma. Nagata H, Kozaki KI, Muramatsu T, Hiramoto H, Tanimoto K, Fujiwara N, Imoto S, Ichikawa D, Otsuji E, Miyano S, Kawano T, Inazawa J. Oncotarget; 2017 Jun 06; 8(23):37740-37750. PubMed ID: 28465481 [Abstract] [Full Text] [Related]
10. A six-CpG panel with DNA methylation biomarkers predicting treatment response of chemoradiation in esophageal squamous cell carcinoma. Chang WL, Lai WW, Kuo IY, Lin CY, Lu PJ, Sheu BS, Wang YC. J Gastroenterol; 2017 Jun 06; 52(6):705-714. PubMed ID: 27671002 [Abstract] [Full Text] [Related]
11. Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus. Hibino S, Kanda M, Oya H, Takami H, Shimizu D, Nomoto S, Hishida M, Niwa Y, Koike M, Yamada S, Nishikawa Y, Asai M, Nakayama G, Fujii T, Sugimoto H, Fujiwara M, Kodera Y. Oncol Rep; 2014 Feb 06; 31(2):693-700. PubMed ID: 24317529 [Abstract] [Full Text] [Related]
14. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma. He Y, Wang Y, Li P, Zhu S, Wang J, Zhang S. Dig Dis Sci; 2011 Mar 06; 56(3):681-8. PubMed ID: 20725785 [Abstract] [Full Text] [Related]